Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock!
about
A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumoursCancer-associated thrombosis: prevention and treatmentToward a core nutraceutical program for cancer management.Tissue factor, angiogenesis and tumour progression.Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatin.Sunitinib in advanced pancreatic neuroendocrine tumors: latest evidence and clinical potential
P2860
Unexpected serious toxicity with chemotherapy and antiangiogenic combinations: time to take stock!
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Unexpected serious toxicity wi ...... binations: time to take stock!
@en
Unexpected serious toxicity wi ...... binations: time to take stock!
@nl
type
label
Unexpected serious toxicity wi ...... binations: time to take stock!
@en
Unexpected serious toxicity wi ...... binations: time to take stock!
@nl
prefLabel
Unexpected serious toxicity wi ...... binations: time to take stock!
@en
Unexpected serious toxicity wi ...... binations: time to take stock!
@nl
P2093
P1476
Unexpected serious toxicity wi ...... binations: time to take stock!
@en
P2093
David Khayat
Gavin M Marx
Nick Pavlakis
Peter Harper
P304
P356
10.1200/JCO.2002.20.6.1446
P407
P577
2002-03-01T00:00:00Z